Found: 26
Select item for more details and to access through your institution.
Phase I pharmacological study of continuous chronomodulated capecitabine treatment.
- Published in:
- Pharmaceutical Research, 2020, v. 37, n. 5, p. 1, doi. 10.1007/s11095-020-02828-6
- By:
- Publication type:
- Article
Pharmacodynamic assay of thymidylate synthase activity in peripheral blood mononuclear cells.
- Published in:
- Analytical & Bioanalytical Chemistry, 2013, v. 405, n. 8, p. 2495, doi. 10.1007/s00216-012-6676-1
- By:
- Publication type:
- Article
Correction of peripheral blood mononuclear cell cytosolic protein for hemoglobin contamination.
- Published in:
- Analytical & Bioanalytical Chemistry, 2013, v. 405, n. 7, p. 2391, doi. 10.1007/s00216-012-6614-2
- By:
- Publication type:
- Article
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 201, doi. 10.1007/s10637-014-0179-1
- By:
- Publication type:
- Article
'Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183'.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 6, p. 1083, doi. 10.1007/s10637-014-0143-0
- By:
- Publication type:
- Article
Food‐effect study on uracil and dihydrouracil plasma levels as marker for dihydropyrimidine dehydrogenase activity in human volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 12, p. 2761, doi. 10.1111/bcp.13719
- By:
- Publication type:
- Article
Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 3, p. 706, doi. 10.1111/bcp.13007
- By:
- Publication type:
- Article
Multiparameter Flow Cytometry Assay for Quantification of Immune Cell Subsets, PD‐1 Expression Levels and PD‐1 Receptor Occupancy by Nivolumab and Pembrolizumab.
- Published in:
- Cytometry. Part A, 2019, v. 95, n. 10, p. 1053, doi. 10.1002/cyto.a.23873
- By:
- Publication type:
- Article
Validation of a multiparameter flow cytometry method for the determination of phosphorylated extracellular-signal-regulated kinase and DNA in circulating tumor cells.
- Published in:
- Cytometry. Part A, 2012, v. 81A, n. 8, p. 664, doi. 10.1002/cyto.a.22049
- By:
- Publication type:
- Article
Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1125, doi. 10.1007/s10637-013-9923-1
- By:
- Publication type:
- Article
Erratum to: Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Human metabolism of [14C]indisulam following i.v. infusion in cancer patients.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 4, p. 317, doi. 10.1007/s10637-005-1440-4
- By:
- Publication type:
- Article
Dihydrofolate Reductase/Thymidylate Synthase Fine-Tunes the Folate Status and Controls Redox Homeostasis in Plants.
- Published in:
- Plant Cell, 2017, v. 29, n. 11, p. 2831, doi. 10.1105/tpc.17.00433
- By:
- Publication type:
- Article
EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 6, p. 855, doi. 10.1093/neuonc/nov273
- By:
- Publication type:
- Article
Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.
- Published in:
- Nucleic Acids Research, 2006, v. 34, n. 6, p. e47, doi. 10.1093/nar/gkl051
- By:
- Publication type:
- Article
Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT).
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 4, p. 750, doi. 10.1002/ijc.21919
- By:
- Publication type:
- Article
Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 1, p. 62, doi. 10.1002/cpt.2608
- By:
- Publication type:
- Article
A phase 0 clinical trial of novel candidate extended-release formulations of capecitabine.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 1, p. 71, doi. 10.1007/s00280-004-0773-6
- By:
- Publication type:
- Article
Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 329, doi. 10.1007/s00280-003-0719-4
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 49, n. 3, p. 201, doi. 10.1007/s002800100371
- By:
- Publication type:
- Article
A Phase I dose‐escalation study of two cycles carboplatin‐olaparib followed by olaparib monotherapy in patients with advanced cancer.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 12, p. 3041, doi. 10.1002/ijc.33498
- By:
- Publication type:
- Article
Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G to C substitution in the first 28-bp tandem repeat of the thymidylate synthase 2 R allele.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 1, p. 245, doi. 10.1002/ijc.29694
- By:
- Publication type:
- Article
Is Higher Docetaxel Clearance in Prostate Cancer Patients Explained by Higher CYP3A? An In Vivo Phenotyping Study with Midazolam.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 2, p. 155, doi. 10.1002/jcph.2362
- By:
- Publication type:
- Article
Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 137, n. 1, p. 1, doi. 10.1007/s11060-017-2691-6
- By:
- Publication type:
- Article